Literature DB >> 32616543

Bioactivation of α,β-Unsaturated Carboxylic Acids Through Acyl Glucuronidation.

Teresa Mulder1, Sudheer Bobba1, Kevin Johnson1, Jessica M Grandner1, Wei Wang1, Chenghong Zhang1, Jingwei Cai1, Edna F Choo1, S Cyrus Khojasteh1, Donglu Zhang2.   

Abstract

After oral administration to monkeys of [14C]GDC-0810, an α,β-unsaturated carboxylic acid, unchanged parent and its acyl glucuronide metabolite, M6, were the major circulating drug-related components. In addition, greater than 50% of circulating radioactivity in plasma was found to be nonextractable 12 hours post-dose, suggesting possible covalent binding to plasma proteins. In the same study, one of the minor metabolites was a cysteine conjugate of M6 (M11) that was detected in plasma and excreta (urine and bile). The potential mechanism for the covalent binding to proteins was further investigated using in vitro methods. In incubations with glutathione (GSH) or cysteine (5 mM), GSH and cysteine conjugates of M6 were identified, respectively. The cysteine reaction was efficient with a half-life of 58.6 minutes (k react = 0.04 1/M per second). Loss of 176 Da (glucuronic acid) followed by 129 Da (glutamate) in mass fragmentation analysis of the GSH adduct of M6 (M13) suggested the glucuronic acid moiety was not modified. The conjugation of N-glucuronide M4 with cysteine in buffer was >1000-fold slower than with M6. Incubations of GDC-0810, M4, or M6 with monkey or human liver microsomes in the presence of NADPH and GSH did not produce any oxidative GSH adducts, and the respective substrates were qualitatively recovered. In silico analysis quantified the inherent reactivity differences between the glucuronide and its acid precursor. Collectively, these results show that acyl glucuronidation of α,β-unsaturated carboxylic acids can activate the compound toward reactivity with GSH, cysteine, or other biologically occurring thiols and should be considered during the course of drug discovery. SIGNIFICANCE STATEMENT: Acyl glucuronidation of the α,β-unsaturated carboxylic acid in GDC-0810 activates the conjugated alkene toward nucleophilic addition by glutathione or other reactive thiols. This is the first example that a bioactivation mechanism could lead to protein covalent binding to α,β-unsaturated carboxylic acid compounds.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Year:  2020        PMID: 32616543     DOI: 10.1124/dmd.120.000096

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  1 in total

1.  Novel advances in biotransformation and bioactivation research - 2020 year in review.

Authors:  S Cyrus Khojasteh; Upendra A Argikar; James P Driscoll; Carley J S Heck; Lloyd King; Klarissa D Jackson; Wenying Jian; Amit S Kalgutkar; Grover P Miller; Valerie Kramlinger; Ivonne M C M Rietjens; Aaron M Teitelbaum; Kai Wang; Cong Wei
Journal:  Drug Metab Rev       Date:  2021-06-24       Impact factor: 6.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.